| DB00398 |
yes |
antagonist |
Sorafenib |
approved|investigational |
DB01268 |
yes |
inhibitor |
Sunitinib |
approved|investigational |
DB04727 |
unknown |
NA |
N-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-5-YL}PHENYL)-N'-[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA |
experimental |
DB04849 |
unknown |
NA |
Cediranib |
investigational |
DB04879 |
unknown |
NA |
Vatalanib |
investigational |
DB05014 |
unknown |
NA |
XL999 |
investigational |
DB05075 |
unknown |
NA |
TG-100801 |
investigational |
DB05146 |
unknown |
NA |
XL820 |
investigational |
DB05198 |
unknown |
NA |
CYC116 |
investigational |
DB05578 |
yes |
antagonist |
Ramucirumab |
approved|investigational |
DB06080 |
unknown |
NA |
ABT-869 |
investigational |
DB06101 |
unknown |
NA |
IMC-1C11 |
investigational |
DB06436 |
unknown |
NA |
Semaxanib |
investigational |
DB06589 |
yes |
inhibitor |
Pazopanib |
approved |
DB06595 |
yes |
inhibitor |
Midostaurin |
approved |
DB06626 |
yes |
inhibitor |
Axitinib |
approved|investigational |
DB06938 |
unknown |
NA |
4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide |
experimental |
DB07183 |
unknown |
NA |
N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide |
experimental |
DB07274 |
unknown |
NA |
N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide |
experimental |
DB07326 |
unknown |
NA |
6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide |
experimental |
DB07333 |
unknown |
NA |
N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE |
experimental |
DB07334 |
unknown |
NA |
N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE |
experimental |
DB07514 |
unknown |
NA |
3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one |
experimental |
DB07528 |
unknown |
NA |
3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one |
experimental |
DB07537 |
unknown |
NA |
N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide |
experimental |
DB08042 |
unknown |
NA |
N~4~-methyl-N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine |
experimental |
DB08519 |
unknown |
NA |
N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine |
experimental |
DB08875 |
yes |
antagonist |
Cabozantinib |
approved |
DB08896 |
yes |
inhibitor |
Regorafenib |
approved |
DB08901 |
unknown |
inhibitor |
Ponatinib |
approved |
DB09078 |
yes |
Inhibitor |
Lenvatinib |
approved |
DB09079 |
yes |
Inhibitor |
Nintedanib |
approved |
DB12307 |
unknown |
NA |
Foretinib |
investigational |